Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Phathom Pharmaceuticals Inc (NASDAQ: PHAT) was $4.38 for the day, down -0.23% from the previous closing price of $4.39. In other words, the price has decreased by -$0.23 from its previous closing price. On the day, 0.79 million shares were traded. PHAT stock price reached its highest trading level at $4.4823 during the session, while it also had its lowest trading level at $4.1615.
Ratios:
Our analysis of PHAT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.54 and its Current Ratio is at 3.58.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on February 14, 2025, initiated with a Overweight rating and assigned the stock a target price of $23.
On May 03, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $24.
Needham reiterated its Buy rating for the stock on January 05, 2024, while the target price for the stock was revised from $23 to $26.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 14 ’25 when Topper James N bought 6,300 shares for $3.32 per share. The transaction valued at 20,919 led to the insider holds 55,623 shares of the business.
Topper James N bought 1,120 shares of PHAT for $3,543 on May 13 ’25. The Director now owns 49,323 shares after completing the transaction at $3.16 per share. On May 09 ’25, another insider, Topper James N, who serves as the Director of the company, bought 35,602 shares for $3.22 each. As a result, the insider paid 114,616 and bolstered with 35,602 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHAT now has a Market Capitalization of 305785760 and an Enterprise Value of 658106752. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.74. Its current Enterprise Value per Revenue stands at 8.04 whereas that against EBITDA is -2.304.
Stock Price History:
The Beta on a monthly basis for PHAT is 0.10, which has changed by -0.57681155 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, PHAT has reached a high of $19.71, while it has fallen to a 52-week low of $2.21. The 50-Day Moving Average of the stock is -2.61%, while the 200-Day Moving Average is calculated to be -54.61%.
Shares Statistics:
PHAT traded an average of 1.67M shares per day over the past three months and 2847840 shares per day over the past ten days. A total of 69.64M shares are outstanding, with a floating share count of 37.92M. Insiders hold about 45.68% of the company’s shares, while institutions hold 57.92% stake in the company. Shares short for PHAT as of 1745971200 were 10918242 with a Short Ratio of 6.54, compared to 1743379200 on 12910348. Therefore, it implies a Short% of Shares Outstanding of 10918242 and a Short% of Float of 26.1.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
